SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doug T. who wrote (4028)6/11/1998 2:19:00 PM
From: Brent  Read Replies (1) of 8798
 
IMNR and AGPH would fit together well:

AGPH is a one-stock company with a great cash flow for next
two years but a poor pipeline. IMNR has a great pipeline but insufficient cash to play all the options. A think
the stalled partnership deals may be because potential partners, knowing IMNR is short of cash, are trying to
extract too good a deal. A merger would let the shareholders of both companies take full value from both the
near term and the long term. Combined market cap today of the two companies is less than $1.4B, but
together they are worth twice that. Imagine if IMNR had the cash to start Phase III on their RA technology
today, or to move aggressively on the gene therapies rather than partner them out to someone else. They have
been forced to put most of their cash into Remune, and the result is the other opportunities are not accreting
value.

(from Yahoo)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext